IPN Ipsen SA

Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights

and shares composing the share capital

(in accordance with Article L.233-8 II of the French Commercial Code and

Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)

Market: Euronext Paris

ISIN Code: FR 0010259150

LEI: 549300M6SGDPB4Z94P11

DateTotal number of shares composing the share capitalTotal number of voting rights (1)
31 December 202583,814,526Gross total* of voting rights: 132,013,627
Net total** of voting rights: 130,586,129

(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).

* Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings.9** Net total = total number of voting rights attached to the total number of shares – shares without voting rights.

Attachment



EN
07/01/2026

Underlying

IPNIpsen SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ipsen SA

 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen - December 2025 - Monthly information relative to the total numb...

Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights (1)31 December 202583,814,526Gross total* of vo...

January 7, 2026 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen - Décembre 2025 - Information mensuelle relative au nombre total...

Ipsen - Décembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerceet à l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : Euronext Paris Code ISIN : FR 0010259150LEI : 549300M6SGDPB4Z94P11 Date Nombre total d’actions composant le capital socialNombre total de droits de vote (1)31 décembre 202583 814 526Total brut* des dro...

January 7, 2026 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen - Bilan semestriel - 31 12 2025

Ipsen - Bilan semestriel - 31 12 2025 Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF PARIS, FRANCE, 06 JANVIER 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd'hui qu’au titre du contrat de liquidité confié par IPSEN S.A. à NATIXIS ODDO BHF, à la date du 31 décembre 2025, les ressources suivantes figuraient au compte de liquidité dédié : 30 064 titres 2 126 437,66 euros Il est rappelé que lors de la mise en place du contrat, les moyens suivants figuraient au compte de liquidité dédié : 12 751 titres3 137 934,80 euros Sur la période du 1er juill...

January 6, 2026 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen – Half year statement – 2025 12 31

Ipsen – Half year statement – 2025 12 31 Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF PARIS, 06 JANUARY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that under the liquidity agreement entrusted by IPSEN S.A. to NATIXIS ODDO BHF, as of December 31, 2025, the following resources were included to the dedicated liquidity account: 30,064 shares €2,126,437.66   It is reminded that as of the date of the signature of the agreement, the following assets were allocated to the liquidity account: 12,751 shares€3,137,934.80 Between July 1st, 2025 and December ...

January 6, 2026 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen expands early development pipeline with Simcere Zaiming’s innova...

Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a LRRC15-targeting antibody-drug conjugateSIM0613 is optimally designed for superior tumor penetration with robust preclinical efficacy dataProgram expected to enter Phase I clinical development in H2 2026Simcere Zaiming is eligible to receive up to $1.06B in total payments PARIS, FRANCE; 22 DECEMBER 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today an exclus...

December 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch